The Biostatistics Shared Resource (BIOSTATS) provides strategic support in the design, oversight, implementation, analysis, publication, and reporting of scientific studies by Roswell Park researchers. In the earliest stages of study development, we help to clarify aims and statistical outcomes, and to develop ethical, rigorous, cost-effective designs. BIOSTATS focus is on conceptualizing and developing research projects, analyses for publication, and the development of methodology clearly and closely related to the support of specific projects within the Cancer Center. BIOSTATS provides support to Roswell Park CCSG investigators in research ranging from laboratory, to clinical, to population studies In the reporting period (2013-2017), BIOSTATS served a total of 195 Roswell users, of which 110 (57%) were CCSG members. BIOSTATS provide a broad range of services including experimental design (including in vitro, animals, clinical trials, epidemiology, and surveys), grant writing and collaboration, hypothesis formulation, exploratory data analysis, fitting models to data, simulation studies, and development novel methods based on emerging technologies (e.g., cutting-edge microarray platforms and computer-intensive statistical methods).
The Specific Aims of BIOSTATS are: 1) To enhance the productivity of Roswell Park investigators by providing rigorous, comprehensive, and collaborative statistical support covering the spectrum of their research studies and grant opportunities; 2) To maintain the integrity of the Roswell Park clinical trial portfolio by actively engaging in its planning, oversight, review and management; and 3) To support the development of the next generation of researchers through formal and ad-hoc training opportunities within Roswell Park, and through Research Assistantships for Biostatistics students. Historically, BIOSTATS personnel focused primarily on clinical trials design and analysis. Great strides have been made over the project period to expand our focus to accommodate the growing needs in health behavior, cancer prevention and epidemiology, while keeping up with the increase of clinical trials and basic research work. BIOSTATS plans to: (i) continue to provide timely statistical support to basic, translational, clinical, and epidemiologic research. This support includes standard methods and novel approaches developed within the shared resource; (ii) adopt adaptive designs for clinical trials; (iii) expand educational activities focused on critical applied topics, such as study design, clinical trial methods, and grant/protocol components; and (iv) enhance BIOSTATS billing, tracking, reporting and other processes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-43
Application #
9923567
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
43
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Rossetti, Stefano; Wierzbicki, Andrzej J; Sacchi, Nicoletta (2018) Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer. Oncotarget 9:5016-5031
Block, Matthew S; Vierkant, Robert A; Rambau, Peter F et al. (2018) MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 93:307-320
Li, Qiuhui; Deng, Qu; Chao, Hsueh-Ping et al. (2018) Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9:3600
Kawaguchi, Tstutomu; Yan, Li; Qi, Qianya et al. (2018) Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol 25:4037-4046
Mett, V; Komarova, E A; Greene, K et al. (2018) Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene 37:439-449
Long, Mark D; Singh, Prashant K; Russell, James R et al. (2018) The miR-96 and RAR? signaling axis governs androgen signaling and prostate cancer progression. Oncogene :
Hirose, Yuki; Nagahashi, Masayuki; Katsuta, Eriko et al. (2018) Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis. Sci Rep 8:10814
Vexler, Albert; Yu, Jihnhee; Zhao, Yang et al. (2018) Expected p-values in light of an ROC curve analysis applied to optimal multiple testing procedures. Stat Methods Med Res 27:3560-3576
Mussell, Ashley L; Denson, Kayla E; Shen, He et al. (2018) Loss of KIBRA function activates EGFR signaling by inducing AREG. Oncotarget 9:29975-29984
Yendamuri, Sai; Groman, Adrienne; Miller, Austin et al. (2018) Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. Eur J Cardiothorac Surg 53:656-663

Showing the most recent 10 out of 1555 publications